Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1973 Aug;8(2):137-44.
doi: 10.1128/iai.8.2.137-144.1973.

Antibody response of hamsters to A2-Hong Kong virus vaccine after priming by heterotypic virus infection

Antibody response of hamsters to A2-Hong Kong virus vaccine after priming by heterotypic virus infection

C W Potter et al. Infect Immun. 1973 Aug.

Abstract

Hamsters previously infected with influenza virus A1/FM/1/47 produced serum hemagglutination inhibition (HI) antibody in response to 1/100 the antigenic dose of inactivated influenza virus A2/Hong Kong vaccine necessary to induce antibody in normal animals. This priming effect was believed to be due to the virus infection which caused an immune response to a virus antigen common to both the infecting virus and the virus vaccine; this antigen acted as a carrier for the specific vaccine virus hemagglutinin and potentiated the immune response to the new antigen. This theory, which has been established in other immune systems, was tested, and the results obtained did not contradict the conditions imposed in the above explanation. Thus, the priming effect could be transferred to normal hamsters by inoculation of spleen cells from virus-infected animals, and the HI antibody response to the virus vaccine was characteristic of a secondary response. The theory also required that the new antigen be coupled to the carrier protein; however, primed hamsters produced serum HI antibody after inoculation with ether-Tween-split virus vaccine, but there was no proof that this vaccine was completely dissociated.

PubMed Disclaimer

References

    1. J Exp Med. 1970 Nov;132(5):1019-34 - PubMed
    1. Proc R Soc Lond B Biol Sci. 1971 Jan 12;176(1045):385-92 - PubMed
    1. Proc R Soc Lond B Biol Sci. 1971 Jan 12;176(1045):393-418 - PubMed
    1. J Exp Med. 1966 Apr 1;123(4):689-705 - PubMed
    1. Immunochemistry. 1965 Sep;2(3):235-54 - PubMed